Prevention of Retinal Thickening and CME Following Phacoemulsification
Showing 9976 - 10000 of >10,000
Prevention of Thromboembolic Events Trial in Kiel (BAY2433334 single dose in treatment groups 1-4 and 6 as well as on the
Completed
- Prevention of Thromboembolic Events
- BAY2433334 single dose in treatment groups 1-4 and 6 as well as on the dialysis free day of treatment 5
- BAY2433334 on dialysis treatment day
-
Kiel, Schleswig-Holstein, GermanyCRS Clinical-Research-Services Kiel GmbH
Dec 20, 2021
Hemophilia A Trial in India (Moroctocog-alfa (AF-CC))
Completed
- Hemophilia A
- Moroctocog-alfa (AF-CC)
-
Surat, Gujarat, India
- +4 more
Apr 30, 2021
Healthy Volunteers - Liver Diseases Trial in Watford (NNC0560-0004, Placebo (NNC0560-0004))
Recruiting
- Healthy Volunteers - Liver Diseases
- NNC0560-0004
- Placebo (NNC0560-0004)
-
Watford, Middlesex, United KingdomNovo Nordisk Investigational Site
Nov 14, 2023
COVID-19 Trial in New York (Nurse-Community-Family Partnership Intervention)
Recruiting
- COVID-19
- Nurse-Community-Family Partnership Intervention
-
New York, New YorkNew York University
Jul 13, 2022
Physical Inactivity, Eating Behavior, Smoking Trial in Vancouver (Health behaviour change)
Not yet recruiting
- Physical Inactivity
- +2 more
- Health behaviour change
-
Vancouver, British Columbia, CanadaUniversity of British Columbia
Jul 12, 2022
Colorectal Adenoma, Metformin, Chemoprevention Trial in Shanghai (low-dose metformin, high-dose metformin, Placebo)
Recruiting
- Colorectal Adenoma
- +2 more
- low-dose metformin
- +2 more
-
Shanghai, Shanghai, ChinaDivision of Gastroenterology and Hepatology, Ren-Ji Hospital, Sh
May 12, 2021
Endophthalmitis, Open Globe Injury, Moxifloxacin Trial in Campinas (Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution,
Recruiting
- Endophthalmitis
- +3 more
- Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution
- Ciprofloxacin 400 MG/200 ML Intravenous Solution [CIPRO IV]
-
Campinas, BrazilUniversity of Campinas
Dec 6, 2021
Prostatic Tumors, Psychological Distress, Physician-Patient Relations Trial in Laval, Montréal, Québec (Let's Discuss Health
Recruiting
- Prostatic Neoplasms
- +6 more
- Let's Discuss Health Group
-
Laval, Quebec, Canada
- +2 more
Mar 24, 2023
Ridge Splitting, i-PRF, Dental Implant Trial in Kafr Ash Shaykh (Immediate implant placement and alveolar ridge splitting with
Completed
- Ridge Splitting
- +2 more
- Immediate implant placement and alveolar ridge splitting with GBR and i-PRF
- Immediate implant placement and alveolar ridge splitting with GBR
-
Kafr Ash Shaykh, EgyptFaculty of Dentistry, Kafrelsheikh University
Apr 1, 2022
Gaucher Disease Trial in Durham, Fairfax (LY3884961, Methylprednisolone, Sirolimus)
Not yet recruiting
- Gaucher Disease
- LY3884961
- +3 more
-
Durham, North Carolina
- +1 more
Aug 1, 2022
Hematoma Postoperative, Venous Thromboembolism Trial in Bronx (Tranexamic acid, Placebo (topical saline))
Completed
- Hematoma Postoperative
- Venous Thromboembolism
- Tranexamic acid
- Placebo (topical saline)
-
Bronx, New YorkMontefiore Medical Center Hutchinson Metro Center Campus
Aug 3, 2022
Attention Deficit/Hyperactivity Disorder Trial in Paris (Self-hypnosis application, Questionnaires)
Not yet recruiting
- Attention Deficit/Hyperactivity Disorder
- Self-hypnosis application
- Questionnaires
-
Paris, FranceHôpital Necker-Enfants Malades
Feb 13, 2023
Immediate and Medium-term Health- and Work-related Effects
Recruiting
- Cardiovascular Diseases
- Psychiatric Disorder
- Psychocardiological Rehabilitation
-
Muthmannsdorf, Lower Austria, AustriaRehabilitationszentrum Felbring
Jul 27, 2022
Glenoid Anchor Peg Component Fixation
Completed
- Arthritis
- CT, X-Ray
- +2 more
- (no location specified)
Nov 4, 2022
Respiratory Syncytial Virus Infections Trial in Worldwide (MEDI8897, Palivizumab)
Active, not recruiting
- Respiratory Syncytial Virus Infections
-
Anaheim, California
- +127 more
Aug 18, 2022
Patients With Fragility Fractures: Application and Efficacy
Recruiting
- Osteoporosis
- Anti-osteoporotic medication( alendronate or denosumab)
-
Heraklion, Crete, GreeceUniversity Hospital of Heraklion
Apr 22, 2021
Marburg Virus Disease Trial in Lenexa (galidesivir, )
Deep Brain Stimulation (DBS) and Motor Evoked Potentials (MEP)
Not yet recruiting
- MEP Onset Latency
- motor evoked potentials
- (no location specified)
Oct 3, 2022
Cancer, Covid19, Respiratory Viral Infection Trial in Melbourne (Interferon alfa, Selinexor, Lenzilumab)
Recruiting
- Cancer
- +2 more
- Interferon alfa
- +2 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Aug 11, 2021
Atrial Fibrillation Trial (Amiigo Watch Only, Amiigo Watch + BodyGuardian)
Withdrawn
- Atrial Fibrillation
- Amiigo Watch Only
- Amiigo Watch + BodyGuardian
- (no location specified)
Sep 7, 2021
Type 2 Diabetes, Insulin Resistance Trial in Maastricht (Fermentable oligosaccharide, Personalized fiber mixture)
Recruiting
- Type 2 Diabetes
- Insulin Resistance
- Fermentable oligosaccharide
- Personalized fiber mixture
-
Maastricht, Limburg, NetherlandsMaastricht University
May 31, 2022
Tuberculosis Trial in Hamilton (Ad5Ag85A)
Completed
- Tuberculosis
- Ad5Ag85A
-
Hamilton, Ontario, CanadaMcMaster University Medical Centre
Oct 25, 2021
Prevention, Overweight and Obesity, Dietary Habits Trial in Stockholm (A Healthy School Start Plus intervention)
Completed
- Prevention
- +4 more
- A Healthy School Start Plus intervention
-
Stockholm, SwedenKarolinska Institutet
Jan 21, 2022
Hypoglycemia and Cardiac Arrhythmias in Type 1 Diabetes
Active, not recruiting
- Diabetes type1
- +2 more
- Hypoglycemic combined with either normo or hyperglycemic clamp.
-
Copenhagen, DenmarkClinical Metabolic Physiology, SDCC
Sep 1, 2021
